Discover
BMRN
BioMarin Pharmaceutical Inc.
69.19
1 x 69.15
1 x 69.20
bid
ask
+
0.31
0.45%
01:34 PM
timesize
| Ytd | 16.42% | |
| 1y | 21.81% |
69.06
day range
70.58
49.67
52 week range
69.17
| Open | 69.50 | Prev Close | 68.88 | Low | 69.06 | High | 70.58 | Mkt Cap | 13.37B |
| Vol | 1.78M | Avg Vol | 2.13M | EPS | 2.08 | P/E | 33.26 | Forward P/E | 9.72 |
| Beta | 0.24 | Short Ratio | 7.70 | Inst. Own | 103.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 58.45 | 200-d Avg | 56.57 | 1yr Est | 89.52 |
| Income Statement | |||
| Total Revenue | 989.71M | ||
| Revenues (USD) | 989.71M | ||
| Cost of Revenue | 202.80M | ||
| Gross Profit | 786.91M | ||
| Operating Expenses | 675.99M | ||
| Research and Development Expense | 206.95M | ||
| Selling, General and Administrative Expense | 395.55M | ||
| Operating Income | 110.92M | ||
| Interest Expense | 63.30M | ||
| Income Tax Expense | 16.62M | ||
| Net Income | 44.76M | ||
| Net Income Common Stock | 44.76M | ||
| Net Income Common Stock (USD) | 44.76M | ||
| Consolidated Income | 44.76M | ||
| Earnings per Basic Share | 0.23 | ||
| Earnings per Basic Share (USD) | 0.23 | ||
| Earnings per Diluted Share | 0.23 | ||
| Earning Before Interest & Taxes (EBIT) | 124.68M | ||
| Earning Before Interest & Taxes (USD) | 124.68M | ||
| Weighted Average Shares | 193.42M | ||
| Weighted Average Shares Diluted | 194.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 874.01M | ||
| Cash and Equivalents (USD) | 874.01M | ||
| Trade and Non-Trade Receivables | 1.06B | ||
| Current Assets | 3.97B | ||
| Property, Plant & Equipment Net | 989.99M | ||
| Total Assets | 11.72B | ||
| Debt Current | 658.20M | ||
| Total Debt | 4.19B | ||
| Current Liabilities | 1.66B | ||
| Debt Non-Current | 3.53B | ||
| Total Liabilities | 5.40B | ||
| Accumulated Retained Earnings (Deficit) | 304.50M | ||
| Accumulated Other Comprehensive Income | -8.78M | ||
| Shareholders Equity | 6.32B | ||
| Shareholders Equity (USD) | 6.32B | ||
| Assets Non-Current | 7.75B | ||
| Total Debt (USD) | 4.19B | ||
| Goodwill and Intangible Assets | 5.54B | ||
| Inventory | 1.78B | ||
| Liabilities Non-Current | 3.74B | ||
| Trade and Non-Trade Payables | 1.01B | ||
| Tax Assets | 888.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 97.64M | ||
| Net Cash Flow from Financing | 2.74B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.20B | ||
| Capital Expenditure | -28.82M | ||
| Issuance (Purchase) of Equity Shares | 6.66M | ||
| Issuance (Repayment) of Debt Securities | 2.74B | ||
| Net Cash Flow from Investing | -5.10B | ||
| Net Cash Flow from Operations | 168.11M | ||
| Effect of Exchange Rate Changes on Cash | -3.04M | ||
| Share Based Compensation | 75.69M | ||